Stocktoria
Phio Pharmaceuticals Corp. PHIO
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2012-05-10
Phio Pharmaceuticals Corp. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Lockshin Curtis | director | 2026-02-05 | Grant | 16,600 | — |
| Freeman Jonathan E | director | 2026-02-05 | Grant | 16,600 | — |
| Deming David H | director | 2026-02-05 | Grant | 23,800 | — |
| Carson Lisa Cabott | Chief Financial Officer | 2026-02-05 | Grant | 47,000 | — |
| BRADFORD PATRICIA A | director | 2026-02-05 | Grant | 18,500 | — |
| Bitterman Robert J | Chairman, Pres. & CEO | 2026-02-05 | Grant | 120,000 | — |
| Bitterman Robert J | Chairman, Pres. & CEO | 2025-12-31 | Buy | 5,000 | $1.03 |
| Bitterman Robert J | Chairman, Pres. & CEO | 2025-12-23 | Buy | 5,000 | $1.02 |
Source: SEC EDGAR filings · CIK 0001533040 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.